Growing community of inventors

Bundoora, Australia

Danielle Colledge

Average Co-Inventor Count = 7.00

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 18

Danielle ColledgeAngeline Ingrid Bartholomeusz (5 patents)Danielle ColledgeAnna Ayres (5 patents)Danielle ColledgePeter William Angus (5 patents)Danielle ColledgeWilliam Sievert (5 patents)Danielle ColledgeJoseph John Sasadeusz (5 patents)Danielle ColledgeStephen Alister Locarnini (4 patents)Danielle ColledgeStephen Locarnini (1 patent)Danielle ColledgeDanielle Colledge (5 patents)Angeline Ingrid BartholomeuszAngeline Ingrid Bartholomeusz (27 patents)Anna AyresAnna Ayres (19 patents)Peter William AngusPeter William Angus (17 patents)William SievertWilliam Sievert (10 patents)Joseph John SasadeuszJoseph John Sasadeusz (9 patents)Stephen Alister LocarniniStephen Alister Locarnini (14 patents)Stephen LocarniniStephen Locarnini (10 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Austin Health (3 from 13 patents)

2. Melbourne Health (2 from 24 patents)

3. Abl Sa (2 from 6 patents)

4. Southern Health (1 from 6 patents)

5. Melborne Health (1 from 1 patent)


5 patents:

1. 9702005 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof

2. 8592143 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof

3. 7846663 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof

4. 7745130 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof

5. 7384747 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/1/2026
Loading…